Where does Cytek Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Cytek Biosciences, Inc. ranks #13,937 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Cytek Biosciences, Inc. hold?

Cytek Biosciences, Inc. holds 21 US utility patents granted between 2019 and 2025, spanning 6 technology areas.

What is Cytek Biosciences, Inc.'s Innovation Score?

Cytek Biosciences, Inc. has an Innovation Score of 33.9 out of 100 (46th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Cytek Biosciences, Inc. focus on?

Cytek Biosciences, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 20 patents, ranking #754 of 7,863 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Cytek Biosciences, Inc.'s patent grant rate increasing or decreasing?

Cytek Biosciences, Inc.'s recent grant velocity is +1500% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Cytek Biosciences, Inc.'s patents?

Cytek Biosciences, Inc.'s patents average 14.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Cytek Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Cytek Biosciences, Inc.

USPTO PatentsView assignee record - 21 granted patents across 6 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Cytek ranks #13,937 of 49,997 tracked US assignees by granted-patent volume, with 21 patents across 6 technology areas.

#13,937
of 49,997 US assignees by volume: 46th percentile
by Innovation Score (33.9/100): 14.3
avg claims per patent: +1500%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R13937 · US Corporation #13,937 · 21 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 21 grants
MID-PACK #13,937/49,997
PHOTO-FINISH CosMED Pharmaceutical
CPC-NARROW G01N · 6 areas
INNOV-THIN 33.9/100
CLAIMS-RICH 14.3 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +1500% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: CosMED Pharmaceutical Co. Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Cytek’s 33.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 10.7 pts (32%) Velocity 5.9 pts (17%) Breadth 8.7 pts (26%) Claim depth 8.6 pts (25%)

Qualcomm Incorporated · highest

85
Cytek Biosciences · this assignee

34
3D Lighting… · lowest

7

What this shows Cytek's Innovation Score is 33.9/100 (46th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Cytek?

Each dot is one of Cytek’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cytek’s own 14.3 claims/patent is ABOVE the 9.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Cytek vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Cytek's grants concentrate

Cytek Biosciences, Inc. is a focused PatentsView assignee: 6 CPC subclasses with 95.2% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2024 (5 grants) versus a trough of 1 in 2019. By volume, Cytek sits between CosMED Pharmaceutical Co. Ltd. and Data Systems Co., Ltd..

Cytek's three-year grant acceleration

Cytek Biosciences, Inc. shows 8 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Cosmed Pharmaceut…

21
Crystalvue Medical

21
Curiteva

21
Custom-pak

21
DA International

21
Daicel-evonik

21
Daizo

21
Data Systems

21
Cytek Biosciences ◀

21

What this shows Cytek holds 21 patents at rank #13,937, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Cytek

By rank, the assignees closest to #13,937 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Cytek's primary technology class.

Cytek's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

34 46th percentile higher than 46% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Cytek Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	1	4.8%
2020	4	19.0%
2021	4	19.0%
2022	2	9.5%
2023	1	4.8%
2024	5	23.8%
2025partial year	4	19.0%

Which technologies does Cytek Biosciences, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 20

G02B - Optical Elements, Systems OR Apparatus 4

G01J - Measurement OF Intensity, Velocity, Spectral Content, Polarisation, Phase OR Pulse Characteristics OF Infrared, Visible OR Ultraviolet LIGHT; COLORIMETRY; Radiation Pyrometry 3

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 3

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 3

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Cytek Biosciences, Inc.'s patent record in context - here's where to go next.

Cytek Biosciences, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 95.2% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #13,937 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Cytek Biosciences, Inc. against CosMED Pharmaceutical Co. Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.